Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dienes

Showing results (701-710 of 715) with videos related to

Pageof 72
Sort By:
Histopathology|May 22, 2024
Severe acute liver disease in adults: Contemporary role of histopathologyAndrew D Clouston, Annette S H Gouw, Dina Tiniakos, et al.
Plos One|July 30, 2014
Anti-HDV IgM as a marker of disease activity in hepatitis deltaAnika Wranke, Benjamin Heidrich, Stefanie Ernst, et al.
The Lancet. Infectious Diseases|March 6, 2019
Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trialHeiner Wedemeyer, Cihan Yurdaydin, Svenja Hardtke, et al.
Journal of Hepatology|June 14, 2021
Development and prognostic relevance of a histologic grading and staging system for alcohol-related liver diseaseCarolin Lackner, Rudolf E Stauber, Susan Davies, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|March 9, 2023
Development of the Illinois Surgical Quality Improvement Collaborative (ISQIC): Implementing 21 Components to Catalyze Statewide Improvement in Surgical CareKarl Y Bilimoria, Michael F McGee, Mark V Williams, et al.
The Behavioral and Brain Sciences|July 22, 2025
Studying unconscious processing: Contention and consensusFrançois Stockart, Maor Schreiber, Pietro Amerio, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 15, 2023
Quality-of-life scores improve after 96 weeks of PEG-IFNa-2a treatment of hepatitis D: An analysis of the HIDIT-II trialKatja Dinkelborg, Julia Kahlhöfer, Petra Dörge, et al.
Therapeutic Advances in Medical Oncology|April 7, 2022
Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1: outcome, safety, and risk factors for relapse in a population-based studyKlaus-Peter Dieckmann, Tomas Pokrivcak, Lajos Geczi, et al.
Journal of the American Academy of Dermatology|December 26, 2024
North American clinical practice guidelines for the medical management of hidradenitis suppurativa in special patient populationsRaed Alhusayen, Serena Dienes, Megan Lam, et al.
Nature Genetics|December 20, 2016
Dynamics of clonal evolution in myelodysplastic syndromesHideki Makishima, Tetsuichi Yoshizato, Kenichi Yoshida, et al.
Pageof 72

Showing results (701-710 of 715) with videos related to

Sort By:
Pageof 72
Histopathology|May 22, 2024
Severe acute liver disease in adults: Contemporary role of histopathologyAndrew D Clouston, Annette S H Gouw, Dina Tiniakos, et al.
Plos One|July 30, 2014
Anti-HDV IgM as a marker of disease activity in hepatitis deltaAnika Wranke, Benjamin Heidrich, Stefanie Ernst, et al.
The Lancet. Infectious Diseases|March 6, 2019
Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trialHeiner Wedemeyer, Cihan Yurdaydin, Svenja Hardtke, et al.
Journal of Hepatology|June 14, 2021
Development and prognostic relevance of a histologic grading and staging system for alcohol-related liver diseaseCarolin Lackner, Rudolf E Stauber, Susan Davies, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|March 9, 2023
Development of the Illinois Surgical Quality Improvement Collaborative (ISQIC): Implementing 21 Components to Catalyze Statewide Improvement in Surgical CareKarl Y Bilimoria, Michael F McGee, Mark V Williams, et al.
The Behavioral and Brain Sciences|July 22, 2025
Studying unconscious processing: Contention and consensusFrançois Stockart, Maor Schreiber, Pietro Amerio, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 15, 2023
Quality-of-life scores improve after 96 weeks of PEG-IFNa-2a treatment of hepatitis D: An analysis of the HIDIT-II trialKatja Dinkelborg, Julia Kahlhöfer, Petra Dörge, et al.
Therapeutic Advances in Medical Oncology|April 7, 2022
Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1: outcome, safety, and risk factors for relapse in a population-based studyKlaus-Peter Dieckmann, Tomas Pokrivcak, Lajos Geczi, et al.
Journal of the American Academy of Dermatology|December 26, 2024
North American clinical practice guidelines for the medical management of hidradenitis suppurativa in special patient populationsRaed Alhusayen, Serena Dienes, Megan Lam, et al.
Nature Genetics|December 20, 2016
Dynamics of clonal evolution in myelodysplastic syndromesHideki Makishima, Tetsuichi Yoshizato, Kenichi Yoshida, et al.
Pageof 72